You are currently browsing the archives for 2 November 2017.
Displaying 1 - 2 of 2 entries.

A company centered on treatments and diagnostics for misfolded proteins diseases.

Amorfix Life Sciences indicators sale and distribution contract with Cedarlane Laboratories Amorfix Life Sciences, a company centered on treatments and diagnostics for misfolded proteins diseases, announced today that it has signed an agreement with Cedarlane Laboratories for the sale and distribution of Amorfix’s proprietary antibodies and reagents. Amorfix has developed the world’s most sensitive diagnostic assays for variant Creutzfeldt-Jakob Disease and for aggregated Abeta, the sign of Alzheimer’s Disease . Consequently, we’ve received several inquiries from investigators involved with protein misfolding studies for our reagents, said Dr haldol depot . George Adams, CEO of Amorfix.

Gingivalis associated with its virulence.

Finding a highly effective treatment for smokers contaminated with P. Gingivalis will end up being easier given that these changes in the bacterium’s ‘properties’ have been identified. University of Louisville researcher, Dr David Scott stated: ‘It has long been known that smokers are even more vunerable to periodontitis than are non-smokers. However, the reasons why are not so clear. Our study shows, for the first time, that components in cigarette smoke alter key characteristics of a major bacterial pathogen which, subsequently, changes how our immune system reacts to it. It could turn out that people need to develop alternate treatment programs for smokers and nonsmokers’..